Federal health officials announced a new initiative on May 11 to address what they describe as the overuse of psychiatric medications, particularly among children. The effort, unveiled at a summit on mental health and overmedicalization, aims to curb what Health Secretary Robert F. Kennedy Jr. characterized as “overprescribing” while emphasizing holistic approaches to care.
The action plan directs federal Health and Human Services agencies to evaluate prescription patterns for psychiatric medications and examine both their benefits and potential harms. The initiative includes education and outreach, policy changes, and measures to bridge treatment gaps.
The American Psychiatric Association, while supporting further investments in research and clinical training, emphasized that concerns about overprescribing should be balanced against underprescribing. The organization’s leadership noted that the initiative does not address broader systemic challenges in mental healthcare, including workforce shortages, limited psychiatric beds, inadequate visit time, barriers to psychotherapy, and insufficient integration of psychiatric expertise in primary care. Dr. Theresa Miskimen Rivera, president of the organization and a clinical professor at Rutgers Robert Wood Johnson Medical School, cautioned that the “oversimplification” overlooks these structural issues.
Other psychiatrists acknowledged the complexity. Dr. Jonathan Alpert, chair of psychiatry and behavioral sciences at Montefiore Medical Center in New York City, noted that while some medications are overprescribed and cause unnecessary side effects and costs, others—like antidepressants and antipsychotics—can be lifesaving.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://us.headtopics.com/news/federal-initiative-aims-to-curb-antidepressant-83236164